As we are still in an uptrend, no reversal decision or reversal change in technical analysis. I am interested to see it go up and continue this rise to higher highs, and until we see sudden change in reversal, I will continue to ride the gravy train, up the streets of san fran!!!
Regeneron Pharmaceuticals (REGN) is a stock that has seen an appreciation in its stock price since the beginning of the year. This trading idea focuses on the company's financial performance and its potential for future growth.
Key Metrics:
Gross Profit Ratio: Regeneron's gross profit ratio currently stands at 87.18%. This metric measures the efficiency and...
When she goes, OH BABY she'll go.
It's a big flag and $REGN has a lot of positivity behind it. People like the company.
IF POWELL IS GOOD. This may be one of the best reactions.
Just based off of the technical analysis, and what I see on the chart. So pretty.
I don't have the algo on in this one so you can have less influence on an opinion.
Gnotz algo:
A price action above 754 supports a bullish trend direction.
The ideal entry price is as close to 750 as possible.
Increase the long exposure for a break above 787.50.
The first target price is set at 807.50.
The second target price is set at 863.00.
Stop-loss 731.00
The PEAD projected a bullish outlook for $REGN after a positive under over reaction following its earnings release placing the stock in drift A with an expected accuracy of 66.67%.
About:-
Regeneron Pharmaceuticals, Inc. is a biotechnology company that discover, invent, develops, manufactures and commercializes medicines for the treatment of serious diseases. The company commercializes medicines and product candidates for eye diseases, allergic and inflammatory diseases, pain, infectious diseases, and rare diseases.
Now about...
Down channel and following up channel
I expect a bullish breakout from the current up channel a continuation from the last move up
This expectation is shown with the bars pattern indicator
Daily timeframe
Looking at the REGN Regeneron Pharmaceuticals options chain ahead of earnings , I would buy the $730 strike price Puts with
2023-2-17 expiration date for about
$16.53 premium.
If the options turn out to be profitable Before the earnings release, I would sell at least 50%.
Looking forward to read your opinion about it.
The Trend Lines are above. If SPX does not decline, all the stocks can start a rally which I expect cannot exceed the ATH. I expect 2024 will be the bigger rally and this year, I expect fluctuations.
Not an investment reccomendation.
Price is above the .236 of the trend up.
Bound in a horizontal trading channel for the time being.
Neutral pattern. Some trade inside the rectangle but it will eventually break to one side or the other.
No recommendation.
EPS (FWD)
42.93
PE (FWD)
17.09
Div Rate (TTM)
-
Short Interest
1.52%
Market Cap
$78.35B
Regeneron Pharmaceuticals, Inc. discovers, invents,...
I am buying $REGN again here.
I like the base, the volume signatures are great and it is showing great strength.
The industry is Biotech (and it is in top 30 industries currently in the stock market)
The IBD RS rating is 95
Fund ownership is increasing:
- notable funds owning it are: American Century Focused Dynam, JP Morgan, FIdelity Contrafun, MFS Frowth,...
The PEAD projected a Bullish outlook for $REGN after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 50%.
REGN Q3 September 2022 earnings are on 11/3 at 6:30am. Regeneron Pharmaceuticals (REGN) reported Q2 June 2022 earnings of $9.77 per share on revenue of $2.9 billion. The consensus earnings estimate was $8.53 per share on revenue of $2.8 billion. Revenue fell 44.4% compared to the same quarter a year ago. REGN short entry based on its $754 all time high major...
